Abstract
Due to the severely immunocompromised state that occurs in a number of oncology patients (with or without chemotherapy), antimicrobial therapy is often indicated. Therapy may be administered in response to a given pathogen at a specific site of infection or oftentimes is administered empirically. Multiple agents are frequently indicated to provide the necessary activity against likely microbial pathogens. This chapter addresses some of the pharmacologic considerations that are involved in the use of these agents. The antimicrobial agents that are commonly used in patients with neoplastic diseases are discussed. The areas of focus are the pharmacokinetic and pharmacodynamic characteristics of these agents as well as the more common adverse events associated with their use in this patient population and the clinically significant drug interactions that may be encountered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
